I.B.N. Savio owns a broad portfolio of pharmaceutical and, more broadly, healthcare products, which it promotes directly through its Savio Pharma Italia division or licenses to third-party companies for commercialization in both domestic and international markets. The company also oversees the full distribution of its products across the country, relying on highly qualified and specialized partners to ensure efficient and professional deliveries.
- Diabetological
-
ANDAMANES - Sitagliptin hydrochloride monohydrate
-
AGEMO - POLYENOIC OMEGAS - Class A - RR - Note 13
-
ALMEIDA - Salbutamol + ipratropium bromide - Class A - RR
-
ALVAND - Levofloxacin - Class A - RR
-
AMOCLA - Amoxicillin + clavulanic acid - Class A - RR
Musculoskeletal
-

ANNISTER
ANNISTER - Cholecalciferol - Class A (RR) - note 96
-

ANNOVA
ANNOVA - Cholecalciferol - Class A (RR) - note 96
-
APONIL - Lacidipine - Class A - RR